SELUTION SLR™ Drug Eluting Balloon (DEB)
INTRODUCTION
SELUTION SLR™ Drug Eluting Balloon is the latest generation drug-eluting balloon technology to ensure a consistent and predictable drug release. This breakthrough technology for coronary interventions delivers sustained limus release for up to 90 days. Such qualities are attributed to its three key features:
1. CELL ADHERENT TECHNOLOGY (CAT)™
CAT™ facilitates drug uptake and retention, in the tissue, with minimal drug loss during the procedure while providing excellent deliverability.
- Mix of phospholipids containing and protecting MicroReservoirs
- 1 μg/mm2 Sirolimus drug dose
2. MICRORESEVOIRS
MicroReservoirs achieve a consistent and predictable drug release, comparable to the latest generation Drug-Eluting Stent Technology
- Millions of homogenous 4 μm particles acting as drug delivery systems
- MicroReservoirs are a mix of 4 µm Sirolimus particles and a biodegradable polymer (PLGA)
3. BROAD SIZE MATRIX
SELUTION SLR™ DEB offers a broader portfolio to extend treatment options for coronary artery disease
- Diameter ranging from 1.50 to 5.00 mm
- Length ranging from 10 to 40 mm
TECHNICAL SPECIFICATION
Please refer to the image below for detailed technical reference.
ORDERING INFORMATION
